Publications by authors named "James D Clelland"

Claim this Profile
A
A proof-of-concept study: investigating the impact of COMT genotype and proline on negative symptoms in Alzheimer's disease.
James D Clelland, Hector W Cure, Ashley M Canizares, Julia H Anderson, Bimala Rawal, Catherine L Clelland

BJPsych Open· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The relationship between COMT, proline, and negative symptoms in clinical high risk and recent psychosis onset.
James D Clelland, Hannah Hesson, Krista Ramiah, Julia Anderson, Abraham Thengampallil, Catherine L Clelland

Transl Psychiatry· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of the impact of antidepressants and other medications on COVID-19 infection risk in a chronic psychiatric in-patient cohort.
Catherine L Clelland, Krista Ramiah, Louisa Steinberg, James D Clelland

BJPsych Open· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjunctive sapropterin dihydrochloride treatment in schizophrenia: A positive proof-of-concept, rater-blind, randomized, multivitamin-controlled study.
Catherine L Clelland, Joshua T Kantrowitz, Tse Choo, James D Clelland, Jeffrey A Lieberman

Schizophr Res· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A tetrahydrobiopterin deficit finding in schizophrenia: A confirmation study.
James D Clelland, Jennifer Smeed, Serge Cremers, Catherine L Clelland

Schizophr Res· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulation of cortical and peripheral GCH1 expression and biopterin levels in schizophrenia-spectrum disorders.
James D Clelland, Laura L Read, Jennifer Smeed, Catherine L Clelland

Psychiatry Res· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vitamin D insufficiency and schizophrenia risk: evaluation of hyperprolinemia as a mediator of association.
James D Clelland, Laura L Read, Valérie Drouet, Angela Kaon, Alexandra Kelly, Catherine L Clelland

Schizophr Res· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utilization of never-medicated bipolar disorder patients towards development and validation of a peripheral biomarker profile.
Catherine L Clelland, Laura L Read, Laura J Panek, Robert H Nadrich, Carter Bancroft, James D Clelland

PLoS One· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evidence for association of hyperprolinemia with schizophrenia and a measure of clinical outcome.
Catherine L Clelland, Laura L Read, Amanda N Baraldi, Corinne P Bart, Carrie A Pappas, James D Clelland

Schizophr Res· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of plasma biopterin levels in psychiatric disorders suggests a common BH4 deficit in schizophrenia and schizoaffective disorder.
Mary Ann Richardson, Laura L Read, Margaret A Reilly, James D Clelland, Catherine L Taylor Clelland

Neurochem Res· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigation of the phenylalanine hydroxylase gene and tardive dyskinesia.
Mary Ann Richardson, Helen M Chao, Laura L Read, James D Clelland, Raymond F Suckow

Am J Med Genet B Neuropsychiatr Genet· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evidence for a tetrahydrobiopterin deficit in schizophrenia.
M A Richardson, Laura L Read, Catherine L Taylor Clelland, Margaret A Reilly, Helen M Chao, James D Clelland

Neuropsychobiology· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Branched chain amino acid treatment of tardive dyskinesia in children and adolescents.
Mary Ann Richardson, Arthur M Small, Laura L Read, Helen M Chao, James D Clelland

J Clin Psychiatry· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of the branched-chain amino acids in the treatment of tardive dyskinesia in men.
Mary Ann Richardson, Margaret L Bevans, Laura L Read, Helen M Chao, James D Clelland

Am J Psychiatry· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phenylalanine hydroxylase gene in psychiatric patients: screening and functional assay of mutations.
Mary Ann Richardson, Laura L Read, James D Clelland, Helen M Chao, Margaret A Reilly

Biol Psychiatry· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis